{"nct_id":"NCT06789913","title":"A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2025-06-13","start_date_type":"ACTUAL","primary_completion_date":"2031-07","primary_completion_date_type":"ESTIMATED","completion_date":"2031-10","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["RLAY"]}